Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven E Lipshultz

Showing results (31-40 of 284) with videos related to

Pageof 29
Sort By:
Expert Opinion on Drug Safety|November 1, 2005
Cardiovascular disease and toxicities related to HIV infection and its therapiesKarolina M Zareba, Tracie L Miller, Steven E Lipshultz
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2007
Dexrazoxane-associated risk for secondary malignancies in pediatric Hodgkin's disease: a claim without compelling evidenceSteven E Lipshultz, Stuart R Lipsitz, Endel John Orav
The American Journal of Cardiology|September 13, 2014
Energy drink-induced near-fatal ventricular arrhythmia prevented by an intracardiac defibrillator decades after operative "repair" of tetralogy of FallotAlexandra E Ward, Steven E Lipshultz, Stacy D Fisher
Current Treatment Options in Cardiovascular Medicine|May 28, 2016
Late Cardiotoxicity: Issues for Childhood Cancer SurvivorsJyothsna Akam-Venkata, Vivian I Franco, Steven E Lipshultz
Atherosclerosis|November 22, 2005
Impact of HIV and highly active antiretroviral therapy on leukocyte adhesion molecules, arterial inflammation, dyslipidemia, and atherosclerosisStacy D Fisher, Tracie L Miller, Steven E Lipshultz
Progress in Pediatric Cardiology|August 25, 2009
Outcome Predictors for Pediatric Dilated Cardiomyopathy: A Systematic ReviewJorge A Alvarez, James D Wilkinson, Steven E Lipshultz
Lancet (London, England)|March 4, 2014
Cardiomyopathy in children: importance of aetiology in prognosis--authors' replySteven E Lipshultz, E John Orav, James D Wilkinson, et al.
Cardiovascular Toxicology|October 8, 2004
Cardiovascular effects of HAART in infants and children of HIV-infected mothersKarolina M Zareba, Jill E Lavigne, Steven E Lipshultz
Circulation. Cardiovascular Imaging|September 20, 2012
Screening for long-term cardiac status during cancer treatmentSteven E Lipshultz, Thomas R Cochran, James D Wilkinson
Expert Opinion on Drug Metabolism & Toxicology|July 7, 2017
Chemotherapy-induced cardiotoxicity in childrenNeha Bansal, Shahnawaz Amdani, Emma R Lipshultz, et al.
Pageof 29

Showing results (31-40 of 284) with videos related to

Sort By:
Pageof 29
Expert Opinion on Drug Safety|November 1, 2005
Cardiovascular disease and toxicities related to HIV infection and its therapiesKarolina M Zareba, Tracie L Miller, Steven E Lipshultz
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2007
Dexrazoxane-associated risk for secondary malignancies in pediatric Hodgkin's disease: a claim without compelling evidenceSteven E Lipshultz, Stuart R Lipsitz, Endel John Orav
The American Journal of Cardiology|September 13, 2014
Energy drink-induced near-fatal ventricular arrhythmia prevented by an intracardiac defibrillator decades after operative "repair" of tetralogy of FallotAlexandra E Ward, Steven E Lipshultz, Stacy D Fisher
Current Treatment Options in Cardiovascular Medicine|May 28, 2016
Late Cardiotoxicity: Issues for Childhood Cancer SurvivorsJyothsna Akam-Venkata, Vivian I Franco, Steven E Lipshultz
Atherosclerosis|November 22, 2005
Impact of HIV and highly active antiretroviral therapy on leukocyte adhesion molecules, arterial inflammation, dyslipidemia, and atherosclerosisStacy D Fisher, Tracie L Miller, Steven E Lipshultz
Progress in Pediatric Cardiology|August 25, 2009
Outcome Predictors for Pediatric Dilated Cardiomyopathy: A Systematic ReviewJorge A Alvarez, James D Wilkinson, Steven E Lipshultz
Lancet (London, England)|March 4, 2014
Cardiomyopathy in children: importance of aetiology in prognosis--authors' replySteven E Lipshultz, E John Orav, James D Wilkinson, et al.
Cardiovascular Toxicology|October 8, 2004
Cardiovascular effects of HAART in infants and children of HIV-infected mothersKarolina M Zareba, Jill E Lavigne, Steven E Lipshultz
Circulation. Cardiovascular Imaging|September 20, 2012
Screening for long-term cardiac status during cancer treatmentSteven E Lipshultz, Thomas R Cochran, James D Wilkinson
Expert Opinion on Drug Metabolism & Toxicology|July 7, 2017
Chemotherapy-induced cardiotoxicity in childrenNeha Bansal, Shahnawaz Amdani, Emma R Lipshultz, et al.
Pageof 29